Is there hope that transpinal direct current stimulation corrects motoneuron excitability and provides neuroprotection in amyotrophic lateral sclerosis?
Abstract:This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
“…As spinal anodal stimulation increases MN excitability [ 16 , 17 ] with effects that could be sustained for weeks [ 18 ], and MN hyperexcitability has been reported in symptomatic SOD mice [ 35 ], anodal stimulation could therefore accelerate the neurodegeneration process and lead to shortened survival of SOD mice. Interestingly, the negative anodal survival trend contradicts the prediction that anodal stimulation would have beneficial effects on G93A mice [ 20 ]. However, many factors could explain this discrepancy between this prediction by Baczyk, Krutki and Zytnicki [ 20 ] and our results: (1) Timepoint : In order to be clinically relevant, our study was completed at symptom onset (P90–P105), whereas Baczyk, Krutki and Zytnicki [ 20 ] study targeted a pre-symptomatic timepoint (around P50–P60).…”
Section: Discussionmentioning
confidence: 95%
“…Interestingly, the negative anodal survival trend contradicts the prediction that anodal stimulation would have beneficial effects on G93A mice [ 20 ]. However, many factors could explain this discrepancy between this prediction by Baczyk, Krutki and Zytnicki [ 20 ] and our results: (1) Timepoint : In order to be clinically relevant, our study was completed at symptom onset (P90–P105), whereas Baczyk, Krutki and Zytnicki [ 20 ] study targeted a pre-symptomatic timepoint (around P50–P60). It is highly likely that excitability changes are dynamic throughout disease progression [ 44 ].…”
Section: Discussionmentioning
confidence: 95%
“…Therefore, increasing MN excitability with anodal stimulation could be beneficial earlier in the disease but harmful by symptom onset. Furthermore, the prediction of Baczyk, Krutki and Zytnicki [ 20 ] of beneficial anodal effects in ALS was not based on survival or behavioral experiments but rather was based on cellular data that anodal stimulation enhanced synaptic inputs to MNs and evoked MN hyperexcitability, along with the prediction that these effects would have a beneficial treatment outcome. Extrapolating the individual MN effects to predict the overall treatment outcome relies on filling gaps in the field’s knowledge of the import of the hypo- and hyperexcitability seen throughout disease progression—that is to say, which is the disease mechanism and which is the protective, compensatory mechanism.…”
Section: Discussionmentioning
confidence: 99%
“…For example, sDCS was suggested by computational models to effectively regulate the dendritic PICs of MNs [ 15 ]. Additionally, recent in vivo studies show subcutaneous spinal DC stimulation (ssDCS) modulates measured electrophysiological properties, resulting in altered excitability of spinal MNs, during and beyond the stimulation period [ 16 , 17 , 18 , 19 , 20 , 21 ].…”
Section: Introductionmentioning
confidence: 99%
“…Specifically, we used daily sessions of non-invasive transcutaneous spinal DC stimulation (tsDCS) with the goal of inducing lasting excitability changes in lumbar spinal MNs to affect motor function loss and survival in ALS via anodal (dorsal-to-ventral) or cathodal (ventral-to-dorsal) stimulation. Due to the physics of the polarizations induced across MNs in the stimulated region [ 15 ], it is expected that the cathodal and anodal orientations will have opposing effects (hyper or hypo-excitation), a phenomenon supported by measured MN changes in previous studies [ 16 , 19 , 20 ]. We hypothesized, therefore, that these opposing effects would make one orientation beneficial and the other harmful to symptom progression.…”
Spinal direct current stimulation (sDCS) modulates motoneuron (MN) excitability beyond the stimulation period, making it a potential neurorehabilitation therapy for amyotrophic lateral sclerosis (ALS), a MN degenerative disease in which MN excitability dysfunction plays a critical and complex role. Recent evidence confirms induced changes in MN excitability via measured MN electrophysiological properties in the SOD1 ALS mouse during and following invasive subcutaneous sDCS (ssDCS). The first aim of our pilot study was to determine the clinical potential of these excitability changes at symptom onset (P90-P105) in ALS via a novel non-invasive transcutaneous sDCS (tsDCS) treatment paradigm on un-anesthetized SOD1-G93A mice. The primary outcomes were motor function and survival. Unfortunately, skin damage avoidance limited the strength of applied stimulation intensity, likewise limiting measurable primary effects. The second aim of this study was to determine which orientation of stimulation (anodal vs cathodal, which are expected to have opposing effects) is beneficial vs harmful in ALS. Despite the lack of measured primary effects, strong trends in survival of the anodal stimulation group, combined with an analysis of survival variance and correlations among symptoms, suggest anodal stimulation is harmful at symptom onset. Therefore, cathodal stimulation may be beneficial at symptom onset if a higher stimulation intensity can be safely achieved via subcutaneously implanted electrodes or alternative methods. Importantly, the many logistical, physical, and stimulation parameters explored in developing this novel non-invasive treatment paradigm on unanesthetized mice provide insight into an appropriate and feasible methodology for future tsDCS study designs and potential clinical translation.
“…As spinal anodal stimulation increases MN excitability [ 16 , 17 ] with effects that could be sustained for weeks [ 18 ], and MN hyperexcitability has been reported in symptomatic SOD mice [ 35 ], anodal stimulation could therefore accelerate the neurodegeneration process and lead to shortened survival of SOD mice. Interestingly, the negative anodal survival trend contradicts the prediction that anodal stimulation would have beneficial effects on G93A mice [ 20 ]. However, many factors could explain this discrepancy between this prediction by Baczyk, Krutki and Zytnicki [ 20 ] and our results: (1) Timepoint : In order to be clinically relevant, our study was completed at symptom onset (P90–P105), whereas Baczyk, Krutki and Zytnicki [ 20 ] study targeted a pre-symptomatic timepoint (around P50–P60).…”
Section: Discussionmentioning
confidence: 95%
“…Interestingly, the negative anodal survival trend contradicts the prediction that anodal stimulation would have beneficial effects on G93A mice [ 20 ]. However, many factors could explain this discrepancy between this prediction by Baczyk, Krutki and Zytnicki [ 20 ] and our results: (1) Timepoint : In order to be clinically relevant, our study was completed at symptom onset (P90–P105), whereas Baczyk, Krutki and Zytnicki [ 20 ] study targeted a pre-symptomatic timepoint (around P50–P60). It is highly likely that excitability changes are dynamic throughout disease progression [ 44 ].…”
Section: Discussionmentioning
confidence: 95%
“…Therefore, increasing MN excitability with anodal stimulation could be beneficial earlier in the disease but harmful by symptom onset. Furthermore, the prediction of Baczyk, Krutki and Zytnicki [ 20 ] of beneficial anodal effects in ALS was not based on survival or behavioral experiments but rather was based on cellular data that anodal stimulation enhanced synaptic inputs to MNs and evoked MN hyperexcitability, along with the prediction that these effects would have a beneficial treatment outcome. Extrapolating the individual MN effects to predict the overall treatment outcome relies on filling gaps in the field’s knowledge of the import of the hypo- and hyperexcitability seen throughout disease progression—that is to say, which is the disease mechanism and which is the protective, compensatory mechanism.…”
Section: Discussionmentioning
confidence: 99%
“…For example, sDCS was suggested by computational models to effectively regulate the dendritic PICs of MNs [ 15 ]. Additionally, recent in vivo studies show subcutaneous spinal DC stimulation (ssDCS) modulates measured electrophysiological properties, resulting in altered excitability of spinal MNs, during and beyond the stimulation period [ 16 , 17 , 18 , 19 , 20 , 21 ].…”
Section: Introductionmentioning
confidence: 99%
“…Specifically, we used daily sessions of non-invasive transcutaneous spinal DC stimulation (tsDCS) with the goal of inducing lasting excitability changes in lumbar spinal MNs to affect motor function loss and survival in ALS via anodal (dorsal-to-ventral) or cathodal (ventral-to-dorsal) stimulation. Due to the physics of the polarizations induced across MNs in the stimulated region [ 15 ], it is expected that the cathodal and anodal orientations will have opposing effects (hyper or hypo-excitation), a phenomenon supported by measured MN changes in previous studies [ 16 , 19 , 20 ]. We hypothesized, therefore, that these opposing effects would make one orientation beneficial and the other harmful to symptom progression.…”
Spinal direct current stimulation (sDCS) modulates motoneuron (MN) excitability beyond the stimulation period, making it a potential neurorehabilitation therapy for amyotrophic lateral sclerosis (ALS), a MN degenerative disease in which MN excitability dysfunction plays a critical and complex role. Recent evidence confirms induced changes in MN excitability via measured MN electrophysiological properties in the SOD1 ALS mouse during and following invasive subcutaneous sDCS (ssDCS). The first aim of our pilot study was to determine the clinical potential of these excitability changes at symptom onset (P90-P105) in ALS via a novel non-invasive transcutaneous sDCS (tsDCS) treatment paradigm on un-anesthetized SOD1-G93A mice. The primary outcomes were motor function and survival. Unfortunately, skin damage avoidance limited the strength of applied stimulation intensity, likewise limiting measurable primary effects. The second aim of this study was to determine which orientation of stimulation (anodal vs cathodal, which are expected to have opposing effects) is beneficial vs harmful in ALS. Despite the lack of measured primary effects, strong trends in survival of the anodal stimulation group, combined with an analysis of survival variance and correlations among symptoms, suggest anodal stimulation is harmful at symptom onset. Therefore, cathodal stimulation may be beneficial at symptom onset if a higher stimulation intensity can be safely achieved via subcutaneously implanted electrodes or alternative methods. Importantly, the many logistical, physical, and stimulation parameters explored in developing this novel non-invasive treatment paradigm on unanesthetized mice provide insight into an appropriate and feasible methodology for future tsDCS study designs and potential clinical translation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.